Cavitation Technologies, Inc.
USD 35 million
Proposed cash consideration, less outstanding liabilities.
Investor relations
Investor Relations
Public announcements and transaction documents relating to BrightFlixx Finance (Luxembourg) S.A.
Latest announcement · 20–21 October 2026
BrightFlixx Finance Commences Cash Tender Offers for Cavitation Technologies, Inc. and Alchemy Beverages, Inc.
Offer commencement: 20 October 2026Public news distribution: 21 October 2026
Tender offers commenced — completion subject to conditions
BrightFlixx Finance (Luxembourg) S.A. announced the commencement of concurrent cash tender offers for all outstanding common shares of Cavitation Technologies, Inc. and Alchemy Beverages, Inc. Both offers commenced on 20 October 2026.
The transaction terms contemplate USD 35 million for Cavitation Technologies, Inc. and USD 7 million for Alchemy Beverages, Inc., each less the respective company’s outstanding liabilities and subject to the terms and conditions in the formal offer documents. The final offer prices will be determined using the outstanding shares and liabilities at the close of the 24 December 2026 record date. Both offers are initially scheduled to expire on 26 January 2027 at 11:59 p.m. Pacific Time, subject to extensions.
Commencement and SEC filing do not constitute SEC approval or completion of the acquisitions. Refer to the formal offer documents for conditions, procedures and subsequent amendments.
Visit shareholder information website (opens in a new tab)View official tender-offer filing (opens in a new tab)Read commencement announcement (opens in a new tab)
20–21 October 2026 · Commencement documents
- Commencement announcement — Official SEC exhibit (opens in a new tab)
News release dated 20 October 2026 announcing both cash tender offers.
- Schedule TO-T (opens in a new tab)
Formal tender-offer statement and index of offer documents and related exhibits.
- Public news release — GlobeNewswire (opens in a new tab)
Original distribution of the commencement announcement on 21 October 2026. Source: BrightFlixx Finance (Luxembourg) S.A.; not independent editorial coverage.
- Public news release — Yahoo Finance / GlobeNewswire (opens in a new tab)
21 October 2026 distribution of the commencement announcement, hosted by Yahoo Finance. Paid press release; not independent editorial coverage.
- Shareholder information website (opens in a new tab)
Dedicated shareholder information for the tender offers. The formal filed offer materials control.
Related coverage — SwissBlockchain
Published 22 October 2026. Includes a reproduction of the 21 October GlobeNewswire release with an introductory summary. Third-party publication, not official offer materials or independent verification; formal offer documents and subsequent amendments control.
Independent video commentary
Corporate Decoder’s commentary on the earlier Form 8-K. External third-party opinion, not official offer materials or an endorsement by BrightFlixx Finance. The link starts at 5:15; it is not a current commencement-status source.
Key dates
- Definitive agreements announced
- Form 8-K of Cavitation Technologies, Inc. filed
- Concurrent tender offers commenced
- Commencement announcement publicly distributed
- Record date for determining final offer prices
- Initial expiration at 11:59 p.m. Pacific Time, subject to extensions
After announcement of the final offer prices, the expiration dates will be extended as necessary to provide shareholders at least 30 business days to review the final prices and decide whether to tender. These dates are stated in the cited documents; subsequent amendments take precedence.
This page is provided for information only and is neither an offer to purchase nor a solicitation to sell securities. The offers are made solely through the applicable Offer to Purchase, Letters of Transmittal and related materials. Shareholders should read the complete SEC filings and all amendments carefully. Completion is subject to the applicable offer conditions.
Historical announcement · 9–13 October 2026
Definitive Agreements for Proposed Cash Tender Offers for Cavitation Technologies, Inc. and Alchemy Beverages, Inc.
Announcement: 9 October 2026Form 8-K filed: 13 October 2026
On 9 October 2026, Cavitation Technologies, Inc. and Alchemy Beverages, Inc. entered into definitive agreements with BrightFlixx Finance (Luxembourg) S.A. for proposed cash tender offers for all outstanding common shares of both companies.
The agreements contemplate USD 35 million for Cavitation Technologies, Inc. and USD 7 million for Alchemy Beverages, Inc., each less the respective company’s outstanding liabilities and subject to the applicable agreement terms and conditions. The announcement includes comments from the Chief Executive Officer of Cavitation Technologies, Inc. and from Dr Kassem Lahham.
Alchemy Beverages, Inc.
USD 7 million
Proposed cash consideration, less outstanding liabilities.
Combined
USD 42 million
Before deductions for liabilities, subject to agreement terms and conditions.
Public news and documents
- Public Announcement — Nasdaq / GlobeNewswire (opens in a new tab)
Announcement published on 9 October 2026.
- Official Press Release — SEC Exhibit 99.1 (opens in a new tab)
Press release furnished with the Form 8-K of Cavitation Technologies, Inc.
- Current Report — Form 8-K of Cavitation Technologies, Inc. (opens in a new tab)
Public report describing the agreements and transaction conditions.
- Definitive Tender Offer Agreements — SEC Exhibit 10.1 (opens in a new tab)
Combined agreements relating to Cavitation Technologies, Inc. and Alchemy Beverages, Inc.
- EDGAR Filing Index and Acceptance Record (opens in a new tab)
Accession number 0001683168-26-007778; filed 13 October 2026.
This page provides information about proposed transactions. It is neither an offer to purchase nor a solicitation to sell securities. Any tender offer will be made through the applicable formal offer documents. Investors should read the relevant SEC filings, tender-offer materials and solicitation/recommendation statements when available. Proposed transactions may not commence or be completed.
Investor questions
Tender offer FAQ
Based on the cited 9–21 October 2026 materials. Formal offer documents and subsequent amendments take precedence.
Schedule a discussion
Schedule a 30-minute discussion with Dr Kassem Lahham through Calendly. Calendly is an external service; your booking details are handled under Calendly’s own privacy policy.
Choose a time